Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 2 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 Temozolomide 6 Radiotherapy 6 fluciclovine F-18 4 Topotecan 4 fluorodopa F 18 3 Biopsy 3 niraparib 2 abemaciclib 2 Standard of Care 2 Specimen Handling 2 Pemetrexed 2 Ketoconazole 2 ulixertinib 1 temsirolimus 1 ribociclib 1 posaconazole 1 poly ICLC 1 pitavastatin 1 pembrolizumab 1 orludodstat 1 lorlatinib 1 larotrectinib 1 infigratinib 1 fisetin 1 fimepinostat 1 evolocumab 1 clevudine 1 X-Rays 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Glioma × Dasatinib × Clear all

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡